Figure 1: Western Blot - Anti-Caspase 9 (cleaved Asp315) Antibody (A94478)
Western blot analysis of lysates from 293 cells, treated with Etoposide 25uM 60' using Anti-Caspase 9 (cleaved Asp315) Antibody. The right hand lane represents a negative control, where the antibody is blocked by the immunising peptide.
Immunohistochemical analysis of paraffin-embedded human lung carcinoma tissue using Anti-Caspase 9 (cleaved Asp315) Antibody. The right hand panel represents a negative control, where the antibody was pre-incubated with the immunising peptide.
Immunohistochemical analysis of paraffin-embedded human liver tissue using Anti-Caspase 9 (cleaved Asp315) Antibody at 1:200 (4°C overnight). Negative control was secondary antibody only.
Immunohistochemical analysis of paraffin-embedded human lung tissue using Anti-Caspase 9 (cleaved Asp315) Antibody at 1:200 (4°C overnight). Negative control was secondary antibody only.
Immunofluorescence analysis of human breast tissue using Anti-Caspase 9 (cleaved Asp315) Antibody (red) at 1:200 (4°C overnight). Cy3 labelled secondary antibody was used at 1:300 (RT 50min). Panel A: Target. Panel B: DAPI. Panel C: Merge.
Immunofluorescence analysis of human breast tissue using Anti-Caspase 9 (cleaved Asp315) Antibody (red) at 1:200 (4°C overnight). Cy3 labelled secondary antibody was used at 1:300 (RT 50min). Panel A: Target. Panel B: DAPI. Panel C: Merge.
